A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib

Clinical trial NCT07164170 · RECRUITING

Trial details

NCT number: NCT07164170
Sponsor: Abbisko Therapeutics Co, Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2025-09-22
Primary completion: 2028-12-30
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.